Mallinckrodt Pharmaceuticals recalls
Mallinckrodt Pharmaceuticals has 2 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 29 May 2019. The most frequent reason is packaging defects.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 29 May 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why mallinckrodt pharmaceuticals is recalled
By year
All mallinckrodt pharmaceuticals recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Amitiza (lubiprostone) capsules, 24 mcg recalledAmitiza | Mallinckrodt Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Amitiza (lubiprostone) capsules, 8 mcg recalledAmitiza | Mallinckrodt Pharmaceuticals | Packaging Defects | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.